BACKGROUND: Microalbuminuria (MAU) is a marker of endothelial dysfunction and a predictor of cardiovascular events. The effects of cigarette smoking on the prevalence of MAU in a high-risk population with arterial hypertension are unclear. METHODS: The International Survey Evaluating Microalbuminuria Routinely by Cardiologists in patients with Hypertension (I-SEARCH) documented the clinical profile of 20,364 patients with arterial hypertension and cardiovascular risk factors. In this population, 13,690 patients had no history of smoking, 4,057 patients were former smokers and 2,617 patients were current smokers. RESULTS: The prevalence of MAU was associated with the smoking status. Consumption of 1-20 cigarettes per day leads to an increase of 6.8% in the prevalence of MAU compared to non-smokers (P < 0.001). Smoking of >20 cigarettes per day was associated with a 12.5% higher prevalence of MAU compared to non-smokers, while former smokers had a 4.7% higher prevalence of MAU. Multivariable analysis revealed that smoking was independently associated with MAU [odds ratio (OR) smoking vs. non-smoking 1.16; 95% confidence interval (CI) 1.01-1.33; P < 0.05]. Particularly, a consumption of >20 cigarettes per day was associated with high odds for MAU (OR 1.33; CI 1.01-1.75; P < 0.05). Interestingly, independently of blood pressure, the use of an angiotensin receptor blocker and an ACE was associated with significantly reduced odds ratio for MAU in the smoking group, while there was no significant association in the non-smoking group. CONCLUSION: The prevalence of MAU in hypertensive patients is higher in smokers than in non-smokers with a strong dose dependency.
BACKGROUND: Microalbuminuria (MAU) is a marker of endothelial dysfunction and a predictor of cardiovascular events. The effects of cigarette smoking on the prevalence of MAU in a high-risk population with arterial hypertension are unclear. METHODS: The International Survey Evaluating Microalbuminuria Routinely by Cardiologists in patients with Hypertension (I-SEARCH) documented the clinical profile of 20,364 patients with arterial hypertension and cardiovascular risk factors. In this population, 13,690 patients had no history of smoking, 4,057 patients were former smokers and 2,617 patients were current smokers. RESULTS: The prevalence of MAU was associated with the smoking status. Consumption of 1-20 cigarettes per day leads to an increase of 6.8% in the prevalence of MAU compared to non-smokers (P < 0.001). Smoking of >20 cigarettes per day was associated with a 12.5% higher prevalence of MAU compared to non-smokers, while former smokers had a 4.7% higher prevalence of MAU. Multivariable analysis revealed that smoking was independently associated with MAU [odds ratio (OR) smoking vs. non-smoking 1.16; 95% confidence interval (CI) 1.01-1.33; P < 0.05]. Particularly, a consumption of >20 cigarettes per day was associated with high odds for MAU (OR 1.33; CI 1.01-1.75; P < 0.05). Interestingly, independently of blood pressure, the use of an angiotensin receptor blocker and an ACE was associated with significantly reduced odds ratio for MAU in the smoking group, while there was no significant association in the non-smoking group. CONCLUSION: The prevalence of MAU in hypertensivepatients is higher in smokers than in non-smokers with a strong dose dependency.
Authors: H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf Journal: JAMA Date: 2001-07-25 Impact factor: 56.272
Authors: Scott D Solomon; Julie Lin; Caren G Solomon; Kathleen A Jablonski; Madeline Murguia Rice; Michael Steffes; Michael Domanski; Judith Hsia; Bernard J Gersh; J Malcolm O Arnold; Jean Rouleau; Eugene Braunwald; Marc A Pfeffer Journal: Circulation Date: 2007-11-19 Impact factor: 29.690
Authors: R Pedrinelli; O Giampietro; F Carmassi; E Melillo; G Dell'Omo; G Catapano; E Matteucci; L Talarico; M Morale; F De Negri Journal: Lancet Date: 1994-07-02 Impact factor: 79.321
Authors: Monica Lisi; Saverio Dragoni; Maria Cristina Leone; Thomas Münzel; John D Parker; Tommaso Gori Journal: Clin Res Cardiol Date: 2013-02-19 Impact factor: 5.460
Authors: Felix Mahfoud; Christian Ukena; Janine Pöss; Peter Bramlage; Massimo Volpe; Martin Thoenes; Roland Schmieder; Michael Böhm Journal: Clin Res Cardiol Date: 2012-04-07 Impact factor: 5.460
Authors: Elizabeth C Oelsner; Pallavi P Balte; Morgan E Grams; Patricia A Cassano; David R Jacobs; R Graham Barr; Kristin M Burkart; Ravi Kalhan; Richard Kronmal; Laura R Loehr; George T O'Connor; Joseph E Schwartz; Michael Shlipak; Russell P Tracy; Michael Y Tsai; Wendy White; Sachin Yende Journal: Am J Respir Crit Care Med Date: 2019-02-01 Impact factor: 30.528